Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial
阿特珠单抗联合新辅助抗人表皮生长因子受体2疗法和化疗治疗人表皮生长因子受体2阳性早期乳腺癌：随机III期IMpassion050试验的主要结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.02772
Huober, Jens; Barrios, Carlos H; Niikura, Naoki; Jarząb, Michał; Chang, Yuan-Ching; Huggins-Puhalla, Shannon L; Pedrini, José; Zhukova, Lyudmila; Graupner, Vilma; Eiger, Daniel; Henschel, Volkmar; Gochitashvili, Nino; Lambertini, Chiara; Restuccia, Eleonora; Zhang, Hong
